Table 1.
Demographic Characteristicsa
| Characteristic | Men in the Control Group | Men With CP/CPPS | P |
|---|---|---|---|
| No. of participants | 48 | 42 | |
| Age, y | .1956 | ||
| Mean (SD) | 34.9 (13.3) | 38.4 (12) | |
| Range | 22.9–63.6 | 21.5–70.5 | |
| Race, % of participants | |||
| North American Indian/Native American | 4.2 | 2.4 | .6378 |
| Asian/Asian American | 8.3 | 2.4 | .2187 |
| Black/African American | 10.4 | 7.1 | .5861 |
| Native Hawaiian/Pacific Islander | 0 | 0 | |
| White | 62.5 | 73.8 | .2521 |
| Other | 14.6 | 7.1 | .2625 |
| Unknown | 0 | 7.2 | |
| Ethnicity, % of participants | |||
| Hispanic/Latino | 29.2 | 19.0 | .2651 |
| Not Hispanic/Latino | 70.8 | 78.6 | .4011 |
| Unknown | 0 | 2.4 | |
| CP/CPPS symptom duration, y | |||
| Mean (SD) | 7.5 (7.1) | ||
| Range | 0.6–32.8 | ||
| NIH-CPSI score | |||
| Pain or discomfort (possible score = 0–21) | <.0001 | ||
| Mean (SD) | 0.4 (1.4) | 11.0 (3.9) | |
| Range | 0–8 | 2–19 | |
| Urination (possible score = 0–10) | <.0001 | ||
| Mean (SD) | 0.8 (1.3) | 4.6 (2.9) | |
| Range | 0–6 | 0–10 | |
| Impact of symptoms and quality of life (possiblescore = 0–12) | <.0001 | ||
| Mean (SD) | 0.6 (1.1) | 8.5 (2.5) | |
| Range | 0–5 | 1–12 |
a CP/CPPS = chronic prostatitis/chronic pelvic pain syndrome; NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index.